PEX4 Antibody

What is PEX4 and why is it important in peroxisome research?

PEX4 is a ubiquitin-conjugating enzyme (E2) that functions in the peroxisomal protein import process. It belongs to the UBC protein family and contains the conserved cysteine residue essential for thioester bond formation with ubiquitin. PEX4 is localized exclusively on the peroxisomal membrane, as demonstrated by subcellular fractionation and immunoelectron microscopy studies . PEX4's significance lies in its role in the recycling of peroxisomal import receptors, particularly PEX5, through ubiquitination. This process is critical for maintaining efficient peroxisomal protein import machinery. Mutations in PEX4 are associated with abnormal protein transport and peroxisome dysfunction, which can lead to various peroxisomal disorders .

What experimental systems are commonly used to study PEX4?

PEX4 has been extensively studied in multiple model organisms including:

• Yeasts such as Hansenula polymorpha, where PEX4 was initially characterized through functional complementation studies

• Plant models, particularly Arabidopsis thaliana, where the apem7 mutant with a proline-to-leucine substitution in PEX4 has been characterized

• Mammalian cell cultures, though the search results provide limited information on these systems

Each model system offers different advantages. Yeast systems allow rapid genetic manipulation and biochemical analysis, while plant models like Arabidopsis provide insights into PEX4 function in multicellular organisms. Research approaches typically involve genetic complementation studies, subcellular fractionation, immunodetection, and in vitro ubiquitination assays to characterize PEX4's enzymatic activities .

How can I validate PEX4 antibody specificity for my experiments?

Validating antibody specificity is crucial for reliable results. Based on the research practices described in the search results, you should:

• Perform Western blot analysis comparing wild-type and pex4 mutant/knockout samples. A specific antibody will show the absence of signal in the mutant/knockout samples .

• Include protein overexpression controls. For example, in the provided studies, researchers used strains overexpressing PEX4 under a strong promoter to confirm antibody specificity. A clear dose-response relationship between signal intensity and PEX4 expression level should be observed .

• Verify the molecular weight of the detected protein. PEX4 appears at approximately 18-22 kDa (variations exist between species), and antibodies should detect a band at this expected size .

• Test antibody performance under both reducing and non-reducing conditions, especially when studying ubiquitin conjugates. This approach revealed that PEX4 forms a ~28 kDa ubiquitin conjugate detectable only under non-reducing conditions in wild-type samples .

• Include positive controls such as recombinant PEX4 protein if available.

How can I distinguish between free and ubiquitin-conjugated forms of PEX4?

Distinguishing between free and ubiquitin-conjugated PEX4 requires specific experimental approaches:

• Use SDS-PAGE under both reducing and non-reducing conditions. In research with Arabidopsis PEX4, the ubiquitin-conjugated form appeared as a ~28 kDa band under non-reducing conditions but was largely absent under reducing conditions in wild-type samples . This difference occurs because the thioester bond between PEX4 and ubiquitin is sensitive to reducing agents.

• Generate a PEX4 active site mutant (C90A in Arabidopsis) as a negative control. This mutation prevents the formation of the thioester bond with ubiquitin. In experiments, PEX4C90A failed to form the 28 kDa conjugate even under non-reducing conditions .

• Perform immunoprecipitation with PEX4 antibodies followed by immunoblotting with ubiquitin antibodies (or vice versa) to confirm that the higher molecular weight band contains both PEX4 and ubiquitin.

• In vitro ubiquitination assays using recombinant PEX4 and rabbit reticulocyte lysates (which contain ubiquitin and E1 enzymes) can further verify the ubiquitination capability of PEX4 and distinguish it from mutant forms .

What approaches can be used to localize PEX4 at the subcellular level?

Several complementary approaches can be used to determine PEX4's subcellular localization:

• Differential centrifugation followed by Western blot analysis. This technique can separate cellular components into different fractions (e.g., P30 - 30,000g pellet, P200 - 200,000g pellet, S200 - 200,000g supernatant). In studies with Hansenula polymorpha, PEX4 was detected in membrane fractions .

• Immunoelectron microscopy provides high-resolution localization data. Using antibodies against PEX4 (labeled with larger gold particles) and peroxisomal matrix proteins like catalase (labeled with smaller gold particles), researchers demonstrated that PEX4 localizes specifically to the peroxisomal membrane . This approach requires:

  • Proper tissue fixation and embedding

  • Specific primary antibodies against PEX4 and known peroxisomal markers

  • Gold-conjugated secondary antibodies of different sizes to distinguish the proteins

  • Access to electron microscopy facilities

• Fluorescence microscopy using fluorescently tagged PEX4 constructs or immunofluorescence with PEX4 antibodies, combined with established peroxisomal markers, can provide additional localization evidence.

• Protease protection assays can determine whether PEX4 is exposed to the cytosol or protected within the peroxisome .

What are the critical considerations when using PEX4 antibodies for immunoprecipitation studies?

When using PEX4 antibodies for immunoprecipitation (IP) studies, researchers should consider:

• Antibody specificity and affinity. Polyclonal antibodies like those developed against amino-terminal fragments of PEX4 (Met1-Glu50) have proven effective in detecting both free and modified forms of PEX4 .

• Preservation of protein-protein interactions. If studying PEX4's interactions with other proteins (e.g., PEX22, PEX5), use gentle lysis conditions that maintain these interactions. The search results indicate that PEX4 interacts with membrane protein PEX22 .

• Maintaining ubiquitin conjugates. When studying ubiquitinated forms of PEX4, include deubiquitinase inhibitors (such as N-ethylmaleimide or ubiquitin aldehyde) in your lysis buffers to prevent deubiquitination during sample preparation.

• Buffer conditions. Since PEX4 is membrane-associated, consider using detergents that effectively solubilize membrane proteins without disrupting antibody-antigen interactions. The particular detergent and concentration should be optimized.

• Controls. Include appropriate negative controls (such as IPs from pex4 mutants or with non-specific antibodies) and positive controls (such as overexpressed tagged PEX4) to validate IP specificity.

Why might Western blots with PEX4 antibodies show unexpected bands or patterns?

Several factors can contribute to unexpected Western blot results when using PEX4 antibodies:

• Post-translational modifications. PEX4 undergoes ubiquitination, resulting in a higher molecular weight band (~28 kDa compared to the ~18-22 kDa unmodified form). This band may appear or disappear depending on the experimental conditions (reducing vs. non-reducing) .

• Mutations affecting PEX4. The apem7 mutation in Arabidopsis PEX4 (P123L) results in abnormal ubiquitination patterns, where the ubiquitinated form remains detectable even under reducing conditions, unlike wild-type PEX4 .

• Sample preparation conditions. The preservation of ubiquitin conjugates depends on buffer composition and treatment conditions. Including deubiquitinase inhibitors can help preserve ubiquitinated forms.

• Cross-reactivity with related proteins. PEX4 belongs to the UBC family, and antibodies might cross-react with related ubiquitin-conjugating enzymes, especially if polyclonal antibodies are used.

• Different isoforms or splice variants. If your experimental system expresses different PEX4 isoforms, additional bands might represent these variants.

To resolve these issues, include appropriate controls (wild-type, mutant, and overexpression samples), and consider using site-directed mutagenesis to create PEX4 variants (such as C90A that prevents ubiquitin conjugation) as analytical tools .

How can I optimize immunohistochemical or immunocytochemical detection of PEX4?

Optimizing immunohistochemical or immunocytochemical detection of PEX4 requires careful consideration of several factors:

• Fixation method. Since PEX4 is a membrane-associated protein, overly harsh fixation might disrupt membrane structure and epitope accessibility. Test both cross-linking fixatives (like paraformaldehyde) and precipitating fixatives (like cold methanol) to determine which best preserves PEX4 antigenicity.

• Permeabilization. Sufficient permeabilization is necessary to allow antibody access to the peroxisomal membrane where PEX4 resides. Detergents like Triton X-100 or digitonin can be used, but concentration and duration should be optimized.

• Antigen retrieval. If using fixed tissues or cells, antigen retrieval methods (heat-induced or enzymatic) might improve antibody binding by unmasking epitopes.

• Blocking conditions. Optimize blocking solutions to reduce background while maintaining specific signal. BSA, normal serum, or commercial blocking reagents at appropriate concentrations should be tested.

• Antibody concentration and incubation conditions. Titrate primary antibody concentration and test various incubation times and temperatures (4°C overnight vs. room temperature for shorter periods).

• Co-localization controls. Include established peroxisomal membrane markers (like PEX14) and matrix proteins (like catalase) to confirm the peroxisomal membrane localization of PEX4 .

• Signal amplification. For low-abundance proteins like PEX4, consider signal amplification methods such as tyramide signal amplification or use of more sensitive detection systems.

How can I study the functional interaction between PEX4 and the receptor recycling machinery?

To investigate the functional relationship between PEX4 and the peroxisomal receptor recycling machinery:

• Analyze PEX5 distribution in wild-type versus pex4 mutant cells. Research has shown that in pex4 mutants, PEX5 abnormally accumulates at the peroxisomal membrane, indicating defective receptor recycling . Perform subcellular fractionation followed by immunoblotting to quantify the ratio of membrane-bound versus cytosolic PEX5.

• Examine post-translational modifications of PEX5. Evidence suggests that membrane-associated PEX5 has a slightly larger molecular size than cytosolic PEX5, potentially due to ubiquitination . Use immunoprecipitation followed by ubiquitin immunoblotting to detect ubiquitinated PEX5.

• Generate PEX4 variants with mutations in the active site (C90A) or disease-associated mutations (P123L) to investigate how these affect PEX5 recycling and ubiquitination patterns .

• Perform in vitro ubiquitination assays using purified components (recombinant PEX4, E1, ubiquitin, and potential substrates like PEX5) to directly test PEX4's ubiquitin-conjugating activity toward specific targets.

• Use proximity labeling techniques (BioID or APEX) with PEX4 as the bait to identify proteins in close proximity to PEX4 at the peroxisomal membrane, potentially uncovering novel components of the receptor recycling machinery.

• Implement time-course experiments using systems where PEX4 activity can be conditionally regulated to observe the dynamics of receptor recycling.

What approaches can be used to study PEX4 mutations and their impact on peroxisome function?

To investigate how PEX4 mutations affect peroxisome function:

• Complementation analysis. Introduce wild-type or mutant versions of PEX4 into pex4-deficient backgrounds to assess functional rescue. This approach has been used successfully in both yeast and plant systems to characterize PEX4 function .

• Peroxisomal protein import assays. Use reporter proteins with peroxisomal targeting signals (like GFP-PTS1) to assess import efficiency in cells expressing wild-type versus mutant PEX4. Defective PEX4 leads to mislocalization of peroxisomal matrix proteins to the cytosol .

• Biochemical analysis of ubiquitination patterns. Compare ubiquitin conjugates formed with wild-type PEX4 versus mutant versions (like the apem7/P123L mutation) under various conditions. The research shows that mutations can alter ubiquitination patterns and stability of these conjugates .

• Structure-function analysis. Create a series of PEX4 mutants targeting different functional domains to map regions critical for interaction with PEX22 (membrane anchor), E1 enzymes, or other components of the ubiquitination machinery.

• Peroxisome morphology and abundance assessment. Analyze how PEX4 mutations affect peroxisome size, number, and distribution using microscopy techniques and peroxisomal markers.

• Proteomics approaches. Perform comparative proteomics on isolated peroxisomes from wild-type versus pex4 mutant cells to identify changes in the peroxisomal proteome that might reveal additional PEX4-dependent processes.

How can PEX4 antibodies be used to study peroxisomal disorders?

PEX4 antibodies can be valuable tools for studying peroxisomal disorders through several approaches:

• Diagnostic immunoblotting. Analyze PEX4 expression levels and modification patterns in patient samples versus healthy controls. Abnormal PEX4 expression or ubiquitination could serve as biomarkers for specific peroxisomal disorders.

• Immunohistochemical analysis of patient tissues. Examine PEX4 localization and peroxisome abundance/morphology in biopsy samples from patients with suspected peroxisomal disorders.

• Functional studies in patient-derived cells. Use PEX4 antibodies to assess whether mutations in other peroxins affect PEX4 localization or function, providing insights into disease mechanisms.

• Investigating therapeutic approaches. Monitor changes in PEX4 expression, localization, or activity in response to potential therapeutic interventions for peroxisomal disorders.

• Study of peroxisome-related secondary complications. Since peroxisomal dysfunction affects multiple cellular pathways, PEX4 antibodies can help investigate how peroxisomal import defects lead to broader cellular dysfunction in various tissues and organs.

• Model validation. Confirm that animal or cellular models of peroxisomal disorders accurately recapitulate the molecular defects observed in patients, including alterations in PEX4 function.

How should researchers interpret contradictory results between in vitro and in vivo PEX4 ubiquitination studies?

The search results reveal interesting discrepancies between in vitro and in vivo ubiquitination patterns of PEX4, particularly regarding the apem7 mutation. Interpreting such contradictions requires careful consideration:

• Consider differences in experimental conditions. In vivo, PEX4 exists in a complex environment with numerous interacting partners and regulatory mechanisms not present in simplified in vitro systems. The search results note that "The difference between the in vivo and in vitro processes could be attributed to conditions related to PEX4, such as the accessibility of other factors interacting with PEX4 directly and indirectly" .

• Examine the presence of peroxisomal membrane proteins. In vivo, PEX4 interacts with membrane proteins like PEX22, PEX2, PEX10, and PEX12, which may affect its conformation and activity . These factors may be absent or present in different concentrations in vitro.

• Analyze the impact of mutations on protein conformation. The apem7 mutation (P123L) may alter PEX4's conformation differently in cellular contexts versus purified systems, affecting accessibility of the active site or interaction surfaces.

• Consider post-translational modifications. Additional modifications present in vivo but not in vitro might affect PEX4 function and ubiquitination patterns.

• Assess experimental artifacts. Some discrepancies might result from experimental artifacts, such as non-specific reactions or altered protein stability under in vitro conditions.

• Design validation experiments. To resolve contradictions, design experiments that bridge the gap between in vitro and in vivo conditions, such as semi-permeabilized cell systems or reconstituted membrane systems containing relevant peroxisomal components.

What are the key considerations when comparing PEX4 function across different species?

When comparing PEX4 function across different species (such as yeasts, plants, and mammals), researchers should consider:

• Evolutionary conservation and divergence. While the core ubiquitin-conjugating function of PEX4 appears conserved, species-specific variations may exist in regulatory mechanisms, interaction partners, or even the exact targets of ubiquitination.

• Expression levels and patterns. The search results indicate that in wild-type Hansenula polymorpha, PEX4 expression levels are very low , but this may vary across species or even tissues within the same organism.

• Subcellular localization differences. While PEX4 localizes to the peroxisomal membrane across species, the mechanisms of membrane association might differ. In Arabidopsis, for example, PEX4 lacks a transmembrane domain but associates with the membrane through interaction with PEX22 .

• Experimental approaches and conditions. Different detection methods, antibody specificities, or experimental conditions used across studies can lead to apparent differences that do not reflect actual biological variations.

• Functional redundancy. Some species might have redundant systems that can compensate for PEX4 deficiency, masking the full spectrum of PEX4 functions.

• Model-specific peroxisome biology. Peroxisome biogenesis, abundance, and function vary considerably across species, which might influence the relative importance and specific roles of PEX4.

How can cutting-edge techniques enhance our understanding of PEX4 function in peroxisome dynamics?

Several emerging techniques can provide new insights into PEX4 function:

• CRISPR-Cas9 genome editing to create precise mutations in PEX4 across different model systems, allowing for detailed structure-function analysis without overexpression artifacts.

• Advanced imaging techniques:

  • Super-resolution microscopy (STED, PALM, STORM) to visualize PEX4 localization with nanometer precision

  • Live-cell imaging with conditionally fluorescent PEX4 to track its dynamics during peroxisome biogenesis and division

  • Correlative light and electron microscopy (CLEM) to combine functional information with ultrastructural details

• Proximity labeling methods (BioID, APEX2, TurboID) fused to PEX4 to identify transient or weak interactors at the peroxisomal membrane that might be missed by conventional co-immunoprecipitation approaches.

• Single-molecule tracking to follow individual PEX4 molecules and understand their dynamics at the peroxisomal membrane.

• Cryo-electron tomography of peroxisomes to visualize PEX4 in its native cellular context and potentially observe structural changes associated with its function.

• Optogenetic approaches to temporally control PEX4 activity and observe immediate consequences for peroxisomal protein import.

• Proteomics approaches:

  • Global ubiquitinome analysis to identify all ubiquitinated proteins affected by PEX4 deficiency

  • Cross-linking mass spectrometry to capture transient PEX4 interactions during the ubiquitination cycle

What role might PEX4 play in cellular pathways beyond peroxisome biogenesis?

While PEX4 is primarily studied in the context of peroxisome biogenesis, emerging research suggests potential broader roles:

• Cellular stress responses. Peroxisomes are important in reactive oxygen species metabolism, and PEX4 dysfunction might impact cellular responses to oxidative stress through altered peroxisome function.

• Metabolic regulation. Peroxisomes participate in lipid metabolism, and PEX4-mediated protein import defects could have wider metabolic consequences beyond peroxisome biogenesis itself.

• Organelle crosstalk. Peroxisomes interact with multiple cellular compartments including mitochondria, the ER, and lipid droplets. PEX4 might influence these inter-organelle relationships through its effects on peroxisome function and abundance.

• Development and differentiation. In multicellular organisms, peroxisome function changes during development and differentiation. PEX4 might play regulatory roles in these processes through its influence on peroxisome biogenesis.

• Non-canonical ubiquitination targets. While PEX5 is a known target affected by PEX4 function, PEX4 might ubiquitinate additional substrates outside the peroxisomal import machinery.

• Signaling pathways. Ubiquitination serves not only for protein degradation but also as a signaling mechanism. PEX4-mediated ubiquitination might function in cellular signaling pathways that extend beyond peroxisome biogenesis.

Investigating these potential broader roles requires techniques that can distinguish direct from indirect effects of PEX4 dysfunction, such as acute inactivation strategies combined with systems biology approaches.

What are the relative advantages of different detection methods for studying PEX4?

Different detection methods offer unique advantages for PEX4 research:

Combining multiple methods provides the most comprehensive understanding of PEX4 biology.

How should researchers design experiments to distinguish direct versus indirect effects of PEX4 dysfunction?

Distinguishing direct from indirect effects of PEX4 dysfunction requires thoughtful experimental design:

• Acute versus chronic interventions. Develop systems for acute inactivation of PEX4 (such as auxin-inducible degron tags or temperature-sensitive alleles) to observe immediate consequences before compensatory mechanisms engage.

• Rescue experiments with structure-function variants. Test whether specific PEX4 mutations that selectively disrupt particular functions (e.g., C90A active site mutant) recapitulate all or only a subset of pex4 null phenotypes .

• Direct substrate identification. Use approaches like ubiquitin remnant profiling to identify proteins with reduced ubiquitination in PEX4-deficient cells compared to controls. These represent potential direct substrates.

• In vitro reconstitution. Reconstitute the minimal system necessary for PEX4-dependent ubiquitination in vitro using purified components to identify direct biochemical activities.

• Separation of function mutations. Generate mutations that disrupt PEX4's interaction with specific binding partners (e.g., PEX22) without affecting its catalytic activity to dissect different aspects of PEX4 function.

• Time-course analyses. Monitor the temporal sequence of events following PEX4 inactivation to distinguish primary (early) from secondary (late) effects.

• Bypass experiments. Test whether artificially targeting potential downstream components can bypass the need for PEX4, confirming their position in the same pathway.

• Genetic interaction studies. Perform epistasis analysis with mutations in genes suspected to function upstream or downstream of PEX4 to establish pathway relationships.